Circuit Breaker Market to Exceed Market Valuation USD 9.4 Billion by 2031
Westford USA, Oct. 25, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global circuit breaker market will reach a value of USD 9.4 Billion by 2031, with a CAGR of…
Producers Online
Finding producers online involves identifying the right platforms, networks, and resources where producers showcase their work or are actively seeking projects. Here are some effective strategies:
When reaching out to producers, be clear about your project needs, budget, and timelines. This helps in finding the right match quickly
Westford USA, Oct. 25, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that the global circuit breaker market will reach a value of USD 9.4 Billion by 2031, with a CAGR of…
DUBLIN, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the…
First to demonstrate clinical benefit in patients with chronic inducible urticaria (CIndU) in large, randomized, placebo-controlled study Favorable safety and tolerability Plan to advance CIndU into Phase 3 developmentCompany to…
Long-term improvements observed in the quartet of findings defining disease modification supports atacicept’s potential to prevent kidney failure in patients with IgAN;Long-term results from the ORIGIN Phase 2b study were…
EAGLE, Idaho and NEW YORK, Oct. 25, 2024 (GLOBE NEWSWIRE) -- PetIQ, Inc. (“PetIQ” or the “Company”) (Nasdaq: PETQ), a leading pet medication, health and wellness company, today announced the…
New APPEAR-C3G data show Fabhalta sustained proteinuria reduction at 12 months1Upon Fabhalta initiation, improvement observed in estimated glomerular filtration rate (eGFR) slope – a key measure of kidney function –…
The detailed study results confirmed interim findings, showing stable kidney function and sustained treatment effect more than 18 months after the last dose of felzartamabFelzartamab, an investigational anti-CD38 monoclonal antibody,…
SHANGHAI, Oct. 27, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility technology company, in partnership with AMD, the high performance and adaptive…
Lyon, le 25 octobre 2024 Dans le contexte du projet d’offre publique visant les actions d’Esker SA (le Projet d’OPA), le document PDF téléchargeable ci-après constitue le communiqué dit «…